You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GYRE Exercise Disclosure
Ye Weiguo · SEC Form 4 · Filed Jun 8, 2026
Exercise
Calculated transaction value
$0
Ye Weiguo Chief Operating Officer
GYRE
Gyre Therapeutics
GYRE
Transaction date
Jun 5, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 3 days later
GYRE daily price context
Close on/before transaction
$6.29
Jun 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 15,401 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001140361-26-024449
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$244.79K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 5, 2026 | $11.55K |
| Gyre Therapeutics, Inc. GYRE | Sale | Jun 5, 2026 | $98.57K |
| Gyre Therapeutics, Inc. GYRE Current | Exercise | Jun 5, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 4, 2026 | $14.68K |
| Gyre Therapeutics, Inc. GYRE | Sale | Jun 4, 2026 | $119.99K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 4, 2026 | $0 |